Poplar Therapeutics Inc. launched on Wednesday capitalized with $50 million Series A financing and led by Chip Baird, the ...
Hyundai CEO José Muñoz said the automaker remains committed to hiring at the plant despite plans to incorporate humanoid ...
BCG Report Assesses 150 Cities Across 20+ Performance IndicatorsCities Such as Singapore, Utrecht, and Berlin Stand Out Within Their Respective Peer GroupsMost Cities Trail 2035 Sustainable Mobility T ...
Daryl Watts entered Tuesday on a five-game point streak (four goals, two assists) and a four-game goal streak. The point ...
The judge cited the Supreme Court's recent decision establishing parents' right to opt kids out of LGBTQ+ inclusive lessons.
The U.S. Department of Justice reveals that Claudio Neves Valente, identified as the shooter who killed two Brown University ...
Authorities say New England Patriots star wide receiver Stefon Diggs is facing strangulation and other criminal charges ...
The Buffalo Sabres host the Boston Bruins after Bowen Byram's two-goal game against the Ottawa Senators in the Sabres' 3-2 overtime win.
There should be ballads written about Willson Contreras' brief time with the Cardinals. From his arrival as the All-Star ...
As snowbird season gets under way, Canadian airlines have reduced capacity to the United States by 10 per cent in the first ...
How a Nonbinary Minister Became America's Most Radical Revolutionary by Nina Sankovitch, available now from Simon & Schulster ...
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.